Envoy Medical Inc has a consensus price target of $7.25 based on the ratings of 3 analysts. The high is $8.5 issued by Ascendiant Capital on June 24, 2024. The low is $6 issued by Lake Street on April 3, 2024. The 3 most-recent analyst ratings were released by Ascendiant Capital, Lake Street, and Lake Street on June 24, 2024, April 3, 2024, and November 28, 2023, respectively. With an average price target of $5.83 between Ascendiant Capital, Lake Street, and Lake Street, there's an implied 99.77% upside for Envoy Medical Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Envoy Medical (NASDAQ:COCH) was reported by Ascendiant Capital on June 24, 2024. The analyst firm set a price target for $8.50 expecting COCH to rise to within 12 months (a possible 191.10% upside). 4 analyst firms have reported ratings in the last year.
The latest analyst rating for Envoy Medical (NASDAQ:COCH) was provided by Ascendiant Capital, and Envoy Medical initiated their buy rating.
There is no last upgrade for Envoy Medical
There is no last downgrade for Envoy Medical.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Envoy Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Envoy Medical was filed on June 24, 2024 so you should expect the next rating to be made available sometime around June 24, 2025.
While ratings are subjective and will change, the latest Envoy Medical (COCH) rating was a initiated with a price target of $0.00 to $8.50. The current price Envoy Medical (COCH) is trading at is $2.92, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.